NVE CORP /NEW/
Carvana reported Q2 revenue of $7.38B, above $6.91B estimates, and EPS of 42 cents vs 36 cents, according to Benzinga Pro. Jim Cramer highlighted Summit Therapeutics as a “great spec” after it reported a smaller-than-expected Q2 loss but said it lacks working capital for 12 months. He also discussed Forgent Power, NVE, and Reddit.
BAKER DANIEL A (President & CEO) sold 20,000 shares of NVE CORP /NEW/ (NVEC) at an average of $114.91 ($114.08–$117.57, $2.30M total) across 3 trades over 2026-07-27 to 2026-07-29.
Simply Wall St reports NVE (NVEC) first-quarter results: revenue of $11.03 million, net income of $6.39 million, and EPS of $1.32 from continuing operations. The stock closed at $117.55, with a 31.6x P/E. The article cites a DCF fair value estimate of $35.32 per share.
Over the past 7 days, alphai's AI scored 1 news story mentioning NVEC (NVE CORP /NEW/). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.
Recent NVEC coverage spans earnings, financial news and market movers.
In the last 30 days, NVEC insiders filed 3 SEC Form 4 transactions — no purchases and 3 sales ($2.3M). The most active reporter was BAKER DANIEL A, President & CEO, with 3 filings.
The catalyst in the text is the sharp price move plus prior Q1 improvement, but no fresh Q2 datapoint is provided.
This is a routine insider open-market sale by the CEO, with no 10b5-1 plan cited, but it does not by itself signal a new fundamental change.
NVEC’s earnings results are used to frame a valuation debate: P/E implies support while DCF implies potential overvaluation.
Post-earnings repricing suggests strong demand read-through for spintronic sensors and couplers, with dividend signaling durability.
The call combines a positive earnings datapoint with product-specific progress (MRI-safe wafer-level sensors) and a CEO succession plan, supporting a constructive near-term sentiment bias.
alphai scores every news story that mentions NVEC with an AI model for sentiment and relevance, and aggregates insider trades from NVE CORP /NEW/'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Carvana reported Q2 revenue of $7.38B, above $6.91B estimates, and EPS of 42 cents vs 36 cents, according to Benzinga Pro. Jim Cramer highlighted Summit Therapeutics as a “great spec” after it reported a smaller-than-expected Q2 loss but said it lacks working capital for 12 months. He also discussed Forgent Power, NVE, and Reddit.
7 min readBAKER DANIEL A (President & CEO) sold 20,000 shares of NVE CORP /NEW/ (NVEC) at an average of $114.91 ($114.08–$117.57, $2.30M total) across 3 trades over 2026-07-27 to 2026-07-29.
2 min readSimply Wall St reports NVE (NVEC) first-quarter results: revenue of $11.03 million, net income of $6.39 million, and EPS of $1.32 from continuing operations. The stock closed at $117.55, with a 31.6x P/E. The article cites a DCF fair value estimate of $35.32 per share.
7 min readInvesting.com reports that NVE Corporation (NASDAQ: NVEC) surged about 55% in a single session after its earnings. The article cites Q1 results: revenue up 81% to $11.0 million, net income up 79% to $6.39 million, and a $1.00-per-share quarterly dividend. It also mentions other ProPicks AI gainers and a U.S. forced-labor tariff update.
7 min readNVE Corp (NVEC) Q1 2027 results showed net income up 79% to $6.39 million, or $1.32 per diluted share, on higher revenue. Operating expenses rose mainly from performance-based compensation, while expense as a % of revenue fell to 15% from 19%. Cash and marketable securities rose to $43.9 million. The company launched two MRI-safe wafer-level chip scale sensors and announced CEO succession.
12 min readNVE CORP /NEW/ (NVEC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 nve_ex99z1.htm PRESS RELEASE Press Release NVE Corporation Reports First Quarter Results and Announces Quarterly Dividend Revenue increases 81% and net income increases 79% EDEN PRAIRIE, Minn.—July 22, 2026—NVE Corporation (Nasdaq: NVEC) announced today financial result
4 min readNVE CORP /NEW/ (NVEC) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. NVE Corp - Form 8-K SEC filing 0000724910 false 0000724910 2026-06-22 2026-06-22 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest
3 min readNVE Corp, a US-based specialist in spintronic sensors and couplers, has maintained a steady profile following its latest earnings and cash dividend declaration. The company focuses on developing semiconductor components that use spintronics for signal processing and sensing, particularly in industrial, medical, and security electronics markets. This niche approach, combined with ongoing shareholder returns, positions NVE Corp as a focused technology stock that appeals to investors interested in specialized sensor technology rather than broad consumer electronics cycles.
2 min readNVE Corporation (Nasdaq: NVEC) announced it will release its financial results for the quarter and fiscal year ended March 31, 2026, on Wednesday, May 6, 2026, after market close. The company will host a quarterly conference call at 4:00 p.m. Central Time on the same day, which will be webcast live on its Investor Events page. Interested parties can dial in or log in to ask questions during the call.
3 min readNVE Corporation (NVEC.US) is scheduled to release its earnings report after the market closes on January 21. Investors and analysts will be closely watching the report for insights into the company's financial performance.
2 min read
